- Corporate Officers - P
- Pienta Kenneth
Insider Trading History of Pienta Kenneth
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pienta Kenneth since 2013.
This trader's CIK number is 1571862.
At the time of last reporting, Pienta Kenneth was the Chief Medical Officer of Cue Biopharma, Inc.. (stock ticker symbol CUE).
Also see all insider trading activities at Cue Biopharma, Inc..
Note that in the past
Pienta Kenneth also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Curis Inc (CRIS) by Pienta Kenneth
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | CRIS | 30,000 | $102,690 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cue Biopharma, Inc. (CUE) by Pienta Kenneth
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | CUE | 2,720 | $40,979 | 33,713 | $509,660 | 33,713 | $129,751 |
| 2017 | CUE | 2,000 | $15,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Pienta Kenneth:
1. Curis Inc (CRIS)
2. Cue Biopharma, Inc. (CUE)
Table 1. Insider trading of Curis Inc (CRIS) by Pienta Kenneth
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-09-16 | CRIS | Buy | 10,000 | 4.37 | 43,690 |
| 2013-11-08 | CRIS | Buy | 20,000 | 2.95 | 59,000 |
Table 2. Insider trading of Cue Biopharma, Inc. (CUE) by Pienta Kenneth
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-03-15 | CUE | Option Ex | 13,000 | 5.00 | 65,000 |
| 2021-03-16 | CUE | Option Ex | 439 | 5.00 | 2,195 |
| 2021-03-15 | CUE | Sale | 13,000 | 15.10 | 196,274 |
| 2021-03-16 | CUE | Sale | 439 | 15.09 | 6,625 |
| 2021-02-17 | CUE | Option Ex | 4,274 | 3.93 | 16,796 |
| 2021-02-16 | CUE | Sale | 16,000 | 15.15 | 242,416 |
| 2021-02-17 | CUE | Sale | 4,274 | 15.05 | 64,345 |
| 2021-02-16 | CUE | Option Ex | 16,000 | 2.86 | 45,760 |
| 2021-01-20 | CUE | Buy | 2,720 | 15.07 | 40,979 |
| 2017-12-27 | CUE | Buy | 2,000 | 7.50 | 15,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Pienta Kenneth
(Chief Medical Officer of Cue Biopharma, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.